OSR Health (OSRHW) Change in Cash (2022 - 2026)
OSR Health (OSRHW) posted Change in Cash of -$48177.7 for Q1 2026, up 88.85% sequentially from -$431931.0 in Q4 2025, and down 103.79% YoY from $1.3 million in Q1 2025.
OSR Health (OSRHW) Change in Cash (2022 - 2026) Analysis & Trends
OSR Health has reported Change in Cash for 5 years, with the latest figure at -$48177.7 in Q1 2026.
- Quarterly Change in Cash fell 103.79% year-over-year to -$48177.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78064.9 (down 93.0% YoY) and the FY2025 annual result came in at $1.4 million, up 964.95% from the prior year.
- Change in Cash rose to -$48177.7 in Q1 2026 per OSRHW's latest filing, from -$431931.0 in the prior quarter.
- Over five years, Change in Cash peaked at $1.3 million in Q1 2025 and troughed at -$431931.0 in Q4 2025.
- A 5-year average of $74154.1 and a median of -$5475.5 in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 22949.74% in 2025, down 2118.41% in 2025.
- Over 5 years, Change in Cash stood at $55666.0 in 2022, then plunged by 176.41% to -$42536.0 in 2023, then declined by 11.27% to -$47328.0 in 2024, then plunged by 812.63% to -$431931.0 in 2025, then jumped by 88.85% to -$48177.7 in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$48177.7, -$431931.0, and $677724.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 225.59 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -37.42 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -35,853.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48,177.73 |
| Dec 31, 2025 | -431,931.00 |
| Sep 30, 2025 | 677,724.00 |
| Jun 30, 2025 | -119,550.37 |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | -47,328.00 |
| Sep 30, 2024 | -103,250.00 |
| Jun 30, 2024 | -5,389.00 |
| Mar 31, 2024 | -5,562.00 |
| Dec 31, 2023 | -42,536.00 |
| Sep 30, 2023 | 56,774.00 |
| Jun 30, 2023 | -347,621.00 |
| Mar 31, 2023 | 224,301.00 |
| Dec 31, 2022 | 55,666.00 |
| Sep 30, 2022 | -5,339.00 |
| Jun 30, 2022 | 57,782.00 |